Stock listing

NYSE:PERF Perfumania Holdings Inc Stock

Follow Perfumania Holdings Inc into a list and get an email when it puts out news.

Delisted NYSE:PERF no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NYSE:PERF
Asset type
Stock
Exchange
NYSE
Currency
USD

Where Perfumania Holdings Inc is listed

ListingExchangeCountryCurrency
NYSE:PERF · This page · DelistedNYSEUnited StatesUSD
OTC:PERFQ · DelistedOTCUnited StatesUSD

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Oct 27, 2026 · Before open+0.7%
Quarter to Jun 30, 2026Jul 27, 2026 · Before open+2.1%
Quarter to Mar 31, 2026Apr 28, 2026 · Before open0.0%
Quarter to Sep 30, 2025Oct 28, 2025 · Before open+4.1%
Quarter to Jun 30, 2025Jul 29, 2025 · Before open−16.3%
Quarter to Mar 31, 2025Apr 28, 2025 · Before open+4.8%
Quarter to Dec 31, 2024Mar 28, 2025+11.3%
Quarter to Sep 30, 2024Oct 29, 2024 · Before open−2.6%
Quarter to Jun 30, 2024Jul 24, 2024 · Before open−4.1%
Quarter to Mar 31, 2024Apr 24, 2024 · Before open−2.6%
All 20 quarters
QuarterResultsShare move
Quarter to Dec 31, 2023Feb 28, 2024 · Before open−1.6%
Quarter to Sep 30, 2023Oct 24, 2023 · After close+2.4%
Quarter to Jun 30, 2023Jul 25, 2023 · After close−0.5%
Quarter to Mar 31, 2023Apr 25, 2023 · After close−0.3%
Quarter to Dec 31, 2022Mar 6, 2023 · After close−17.8%
Quarter to Sep 30, 2022Nov 30, 2022 · Before open−0.7%
Quarter to Jun 30, 2022Jul 28, 20220.0%
Quarter to Mar 31, 2022May 5, 2022−0.1%
Quarter to Dec 31, 2021Mar 17, 2022−0.1%
Quarter to Sep 30, 2021Nov 3, 2021+0.1%

Open Events

Cap table

Built by 6ix from Perfumania Holdings Inc’s releases

Common shares
85,059,953
Fully diluted
85,059,953

Fully diluted

LineShares
Common shares85,059,953

Share count over time

CountShares
Nov 22, 202685,059,953

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael Nofi
Other companies: Edgewise Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 10, 2025); SpringWorks Therapeutics Inc (Chief Accounting Officer · Since at least Nov 11, 2019)
CFO · Apr 28, 2017 – Apr 28, 2017 · Past
Donna Dellomo
Other companies: The Lovesac Company (EVP and CFO · Jun 26, 2018 – Jun 7, 2023 · Past)
Chief Financial Officer · Jul 15, 2016 – Jul 15, 2016 · Past
Glenn H Nussdorf
Other companies: Organogenesis Holdings Inc. (Director · Since at least Dec 10, 2018)
Director · Oct 11, 2017 – Oct 11, 2017 · Past
Arlene NussdorfDirector · Oct 11, 2017 – Oct 11, 2017 · Past
Carole Ann TaylorDirector · Dec 11, 2013 – Dec 10, 2014 · Past
Joshua J AngelDirector · Apr 20, 2016 – Apr 20, 2016 · Past
Michael W KatzPresident and CEO, Director · Oct 11, 2017 – Oct 11, 2017 · Past
Paul GarfinkleDirector · Oct 11, 2017 – Oct 11, 2017 · Past
Rafael VilloldoVice President · Sep 6, 2012 – Sep 6, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Perfumania Holdings Inc.